FDA Adverse Event Reporting Systems Consolidation

The U.S. Food and Drug Administration (FDA), part of the Department of Health and Human Services, is seeking qualified small business vendors to support the consolidation of its Adverse Event Reporting Systems. The objective of this procurement is to modernize and enhance the existing adverse event reporting and product quality systems, primarily for the Center for Drug Evaluation and Research, while also benefiting other FDA centers through a unified IT infrastructure. This initiative is crucial for streamlining operations, improving public health outcomes, and ensuring regulatory compliance across multiple FDA centers. Interested parties should submit a brief Capabilities Statement to Narissa Charles at narissa.charles@fda.hhs.gov by the specified deadline, with the opportunity set aside for small businesses under the SBA guidelines.